IRIS
RADAELLI, MARTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 485
NA - Nord America 318
AS - Asia 240
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.052
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 317
SE - Svezia 298
SG - Singapore 113
CN - Cina 91
RU - Federazione Russa 64
IT - Italia 48
FI - Finlandia 15
NL - Olanda 15
IE - Irlanda 13
IR - Iran 12
DE - Germania 10
GB - Regno Unito 9
JP - Giappone 9
IN - India 7
TR - Turchia 6
CH - Svizzera 5
CO - Colombia 4
BR - Brasile 3
EU - Europa 2
HU - Ungheria 2
PT - Portogallo 2
AL - Albania 1
CA - Canada 1
FR - Francia 1
HK - Hong Kong 1
KG - Kirghizistan 1
LU - Lussemburgo 1
NO - Norvegia 1
Totale 1.052
Salva come PNG Salva come JPEG
Città #
Singapore 77
Lawrence 72
Princeton 72
Shanghai 32
Moscow 28
Boardman 23
New York 23
Milan 19
Ashburn 16
Dublin 13
Helsinki 13
Rome 11
Beijing 8
Dronten 8
Tehran 8
Guangzhou 5
Pune 5
Zurich 5
Izmir 4
Medellín 4
Washington 4
Gronau 3
Ikejiri 3
Los Angeles 3
Manchester 3
Seattle 3
Tokyo 3
Amsterdam 2
Ankara 2
Bergamo 2
Dallas 2
Edgware 2
Jiaxing 2
Lappeenranta 2
Mumbai 2
Redhill 2
Shenzhen 2
Wuxi 2
Anshan 1
Bishkek 1
Brierley Hill 1
Buccinasco 1
Budapest 1
Castelseprio 1
Cheyenne 1
Dalian 1
Foshan 1
Frankfurt am Main 1
Fremont 1
Heinrichsthal 1
Kyoto 1
Lisbon 1
Luxembourg 1
Munich 1
Newark 1
Nishikicho 1
Oldbury 1
Oslo 1
Rockville 1
Sapporo 1
Secaucus 1
Senigallia 1
Sopron 1
Sunapee 1
Taizhou 1
Tirana 1
Vaprio d'Adda 1
Xi'an 1
Totale 520
Salva come PNG Salva come JPEG
Nome #
Magnetic Resonance Imaging Evaluation of Perivascular Space Abnormalities in Neuromyelitis Optica 40
Autologous haematopoietic stem cell transplantation with thiotepa-cyclophosphamide conditioning in aggressive multiple sclerosis: clinical experience in eight patients 38
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study 30
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 27
U-Fiber Leukoencephalopathy Due to a Novel Mutation in the TACO1 Gene 27
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 25
Mapping white matter damage distribution in neuromyelitis optica spectrum disorders with a multimodal MRI approach 23
Critical role for prokineticin 2 in CNS autoimmunity 22
Brain and cord imaging features in neuromyelitis optica spectrum disorders 22
Forceps minor damage and co-occurence of depression and fatigue in multiple sclerosis 21
Cross-modal plasticity among sensory networks in neuromyelitis optica spectrum disorders 21
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response 21
Autologous haematopoietic stem cell transplantation in aggressive forms of neuromyelitis optica (NMO) and NMO spectrum disorders 19
Allogeneic haematopoietic stem cell transplantation in refractory neuromyelitis optica spectrum disorders 19
Dysregulation of MS risk genes and pathways at distinct stages of disease 19
Subclinical neurodegeneration in multiple sclerosis and neuromyelitis optica spectrum disorder revealed by optical coherence tomography 19
Basal vitamin D levels and disease activity in multiple sclerosis patients treated with fingolimod 18
In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis 18
A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis 17
Breastfeeding is not related to postpartum relapses in multiple sclerosis 17
Efficacy and safety of nabiximols (Sativex (R)) on multiple sclerosis spasticity in a real-life Italian monocentric study 17
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy 17
Caesarean section and infant formula feeding are associated with an earlier age of onset of multiple sclerosis 17
Clinical and MRI predictors of response to interferon‐beta and glatiramer acetate in relapsing–remitting multiple sclerosis patients 16
Depressive symptoms correlate with disability and disease course in multiple sclerosis patients: An Italian multi-center study using the Beck Depression Inventory 16
Functional network connectivity abnormalities in multiple sclerosis: Correlations with disability and cognitive impairment 15
Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patients 15
Smart watch, smarter EDSS: Improving disability assessment in multiple sclerosis clinical practice 15
Concurrence of NMOSD and ALS in a patient with hexanucleotide repeat expansions of C9orf72 15
Autologous Bone Marrow Transplantation for the Treatment of Multiple Sclerosis 14
Natalizumab treatment after autologous haematopoietic stem cell transplantation in patients with aggressive multiple sclerosis 14
Sars-CoV2 infection in pregnant women with multiple sclerosis 13
Comparative study of mitoxantrone efficacy profile in patients with relapsing-remitting and secondary progressive multiple sclerosis. 13
THIOTEPA-CYCLOPHOSPHAMIDE HIGH-DOSE IMMUNOSUPPRESSIVE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN AGGRESSIVE FORMS OF MULTIPLE SCLEROSIS: RESULTS IN 9 PATIENTS 13
Thiotepa-cyclophosphamide high-dose immunosuppressive therapy with autologous haematopoietic stem cell transplantation in aggressive forms of multiple sclerosis: results in 9 patients 13
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs. 13
Cohort profile: a collaborative multicentre study of retinal optical coherence tomography in 539 patients with neuromyelitis optica spectrum disorders (CROCTINO) 13
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study 12
Mapping regional grey and white matter atrophy in relapsing-remitting multiple sclerosis. 12
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks. 12
Functional brain connectivity abnormalities and cognitive deficits in neuromyelitis optica spectrum disorder 12
Neuromyelitis optica spectrum disorders: Long-term safety and efficacy of rituximab in Caucasian patients 12
Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis 12
Identifying neuropathic pain in patients with multiple sclerosis: a cross-sectional multicenter study using highly specific criteria. 12
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks. 12
Impact of MS genetic loci on familial aggregation, clinical phenotype, and disease prediction. 12
the multiple sclerosis knowledge Questionnaire: a self administered instrument of recently diagnosed patients 11
Dynamic pattern of clinical and MRI findings in a tumefactive demyelinating lesion: a case report 11
Efficacy and tolerability of natalizumab in relapsing-remitting multiple sclerosis patients: A post-marketing observational study 11
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: An Italian multicenter study 11
Practice of yoga may cause damage of bothsciaticnerves: a case report 10
Multiple sclerosis progression is not associated with birth timing in Italy 10
Regional gray matter atrophy is largely unrelated to white matter tissue loss in relapsing remitting multiple sclerosis. 10
Evoked Potential Abnormalities Predict Disability Progression at 5 Years in Patients with CIS 10
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis 10
Necrotic-hemorrhagic myelitis: A rare malignant variant of parainfectious acute disseminated encephalomyelitis in childhood 10
Disclosing the diagnosis of multiple sclerosis: The Profile Project 10
Oral fingolimod (FTY720) in multiple sclerosis: Two-year results of a phase II extension study 10
Recurrence of disease activity after repeated Natalizumab withdrawals. 9
Mitoxantrone: benefits and risks in multiple sclerosis patients 9
Evoked potentials scores: a useful tool in monitoring and predicting the course of multiple sclerosis? 9
Optical coherence tomography and visual-evoked potentials: which is more sensitive in multiple sclerosis? 9
Neuromyelitis optica remission after allo-SCT: results in 2 patients and correlation with T- and B-cell biomarkers of tolerance 9
Differential diagnosis of optic neuritis in neuromyelites optica and multiple sclerosis: are VEPs useful? 9
MGAT5 and disease severity in progressive multiple sclerosis 9
Oral corticosteroids for multiple sclerosis relapse 9
Experience of an information aid for newly diagnosed multiple sclerosis patients: A qualitative study on the SIMS-Trial 9
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 8
Implementation of the 'Sapere Migliora' information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial. 8
NMO spectrum disorder and optic neuritis: are VEPs useful? 8
Evolving concepts in the treatment of relapsing multiple sclerosis 8
Neuromyelitis optica: Concepts in evolution 8
Prognostic value of serum neurofilaments in patients with clinically isolated syndromes 8
Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results 8
Hippocampal-DMN disconnectivity in MS is related to WM lesions and depression 8
Signs and symptoms of COVID-19 in patients with multiple sclerosis 7
Long-term management of natalizumab discontinuation in a large monocentric cohort of multiple sclerosis patients. 7
Stem Cell-Based Therapies, Remyelination, and Repair Promotion in the Treatment of Multiple Sclerosis 6
Evoked potential abnormalities predict disability progression at 5 years in patients with CIS 6
Totale 1.115
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.909
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.909
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 0 0 0 0 2 2 0 0
2020/202111 0 0 2 0 1 2 2 0 3 0 1 0
2021/202244 0 0 0 30 1 2 1 3 2 3 0 2
2022/2023504 182 129 55 2 5 60 19 15 19 6 9 3
2023/2024229 7 26 22 26 27 42 4 20 0 7 10 38
2024/2025284 130 14 20 59 61 0 0 0 0 0 0 0
Totale 1.115